Scoping review of biological treatment of deficiency of interleukin-36 receptor antagonist (DITRA) in children and adolescents.
Hospach T, Glowatzki F, Blankenburg F, Conzelmann D, Stirnkorb C, Müllerschön CS, von den Driesch P, Köhler LM, Rohlfs M, Klein C, Hauck F.
Hospach T, et al.
Pediatr Rheumatol Online J. 2019 Jul 8;17(1):37. doi: 10.1186/s12969-019-0338-1.
Pediatr Rheumatol Online J. 2019.
PMID: 31286990
Free PMC article.
Review.
BACKGROUND: Deficiency of interleukin-36 receptor antagonist (DITRA) is a life threatening monogenic autoinflammatory disease caused by loss of function mutations in the IL36RN gene. ...
BACKGROUND: Deficiency of interleukin-36 receptor antagonist (DITRA) is a life threatening monogenic auto …